Emmaus Life Sciences Receives Notice of FDA PDUFA Date for Investigational L-glutamine Treatment for Sickle Cell DiseaseNovember 30, 2016 Read More
Emmaus’ New Drug Application for Sickle Cell Disease Accepted for Review by FDANovember 08, 2016 Read More
Emmaus Life Sciences Submits New Drug Application for Sickle Cell Disease TreatmentSeptember 08, 2016 Read More
Emmaus Life Sciences Joins New Sickle Cell Disease Coalition, Issues Call To Action To Improve Treatment And CareSeptember 06, 2016 Read More
